The redesigned clariti® 1 day multifocal 3 Add1 features Optimized Comfort Edge™ design that helps provide a high level of comfort from the first fit1,2 for your patients with presbyopia.
When it comes to a successful contact lens wearing experience, patients with presbyopia desire comfort, a key deliverable in their expectations of a multifocal contact lens.3-6
Recent studies report that patients with presbyopia prefer contact lens correction when comfort and good vision can be attained.3 Yet many multifocal contact lens wearers discontinue use due to an uncomfortable wearing experience.5,6 We also know comfort is at the top of the want list for new multifocal contact lens wearers.7
Enter CooperVision’s latest innovation in a 1 day multifocal,8 the new clariti® 1 day multifocal 3 Add. True to the clariti® 1 day family, the clariti® 1 day multifocal 3 Add features important innovations9 at an excellent value.2 The new clariti® 1 day multifocal 3 Add features Binocular Progressive System™ that delivers clear vision at all distances and for all levels of presbyopia,10 in addition to Optimized Comfort Edge™ that helps provide a high level of comfort for wearers.1
New Edge for Improved Comfort Shows Strong Clinical Results11
From the first fit,2 eye care professionals can rely on clariti® 1 day multifocal 3 Add’s Optimized Comfort Edge™ to help provide a high level of comfort2 for their patients with presbyopia. The new edge in the multifocal 3 Add is also found in clariti® 1 day sphere.
For your patients with presbyopia wearing the current 2 Add design, expect a comfort boost*11 when you easily refit them in the new 3 Add.11
A recent prospective study that included 58 soft multifocal contact lens wearers across four U.S. clinical sites found the new clariti® 1 day multifocal 3 Add enhanced the patient wearing experience compared to the original 2 Add design.†11 Further, the new clariti® 1 day multifocal 3 Add met or exceeded the comfort needs of patients on day 1 and day 13 *11 and surpassed the comfort needs of current clariti® 1 day multifocal 2 Add. wearers.* 11
A second study at a single site in the UK enrolled 90 patients, representing a cross-section of emergent, established, and advanced fulltime multifocal contact lens wearers.12 After 1 week of wear, the investigators found clariti® 1 day multifocal 3 Add showed high levels of comfort after 1 week and was no different in comfort than a similarly priced moist 1 day multifocal.12
All-day Comfort‡ with Wetloc® Technology
A cornerstone of the comfort story behind clariti 1 day multifocal 3 add is WetLoc® Technology which supports good all-day comfort.‡ Wetloc® Technology locks in moisture and distributes water molecules throughout the contact lens§ mimicking the moisture dispersion of naturally healthy eyes. By locking in moisture, WetLoc® Technology keeps the contact lens and its surfaces continually moist throughout your patient’s day.
Rounding out the wearing experience is breathable silicone hydrogel material that allows 100% corneal oxygen consumption to help maintain ocular health during daily wear.13
Rely on clariti® 1 day multifocal for your Patients with Presbyopia14-18
Studies show that clariti® 1 day multifocal meets the needs of contact lens patient with presbyopia, including delivering on comfort.14-18 clariti® 1 day multifocal offers excellent comfort at dispensing4 and 87% of wearers agree that they can’t feel the lenses on their eyes.16
Discover more about the new clariti® 1 day multifocal 3 Add with Optimized Comfort Edge™ design and Wetloc® Technology for your patients with presbyopia. Also visit CooperVision’s Online Success Center for additional information and learnings about the new clariti® 1 day multifocal 3 Add.
§ Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed
* Days 1 and 13, p<0.05.
† Distance logMAR VA -0.05 vs -0.02 (p < 0.01), near VA 0.06 vs 0.11 (p = 0.02) for BPS vs 2 ADD respectively.
‡ Manufacturer's quoted core water content.
1. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add with a rating of 88 out of 100; n=90 habitual MFCL wearers
2. CVI data on file, 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 Add; with a rating of 93 out of 100; n=90 habitual multifocal contact lens wearers.
3. Rueff EM, Bailey MD. Presbyopic and non-presbyopic contact lens opinions and vision correction preferences. Cont Lens Anterior Eye. 2017 Oct;40:323-328.
4. Rueff EM, Varghese RJ, Brack TM, Downard DE, Bailey MD. A survey of presbyopic contact lens wearers in a university setting. Optom Vis Sci. 2016 Aug;93:848-854.
5. Sulley A, Young G, Hunt C. Factors in the success of new contact lens wearers. Cont Lens Anterior Eye. 2017 Feb;40:15-24.
6. Novillo-Diaz E, Villa-Collar C, Narvaez-Pena M, Martin JLR. Fitting success for three multifocal designs: multicentre randomised trial. Cont Lens Anterior Eye. 2018 Jun;41:258-
7. CooperVision data on file 2020. Italy n=100 & Japan n= 49 new wearers in 1 Day SiHy.
8. CVI data on file as of May 2023 vs. leading manufacturers.
9. CVI data on file, 2022.
10. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with ratings from 85 to 89 out of 100; n=90 habitual MFCL wearers.
11. CVI data on file, 2022. Prospective, crossover, bilateral, subject masked, daily wear, dispensing study (4 clinical sites in U.S.) (n=58 habitual soft multifocal contact lens wearers).
12. CVI data on file 2021. Prospective, double-masked, randomized, bilateral, one-week cross-over dispensing study with clariti® 1 day multifocal 3 add and 1-DAY ACUVUE® MOIST MULTIFOCAL; n=90 habitual MFCL wearers.
13. Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472.
14. CVI data on file 2021. Prospective, double-masked, randomized, bilateral, one-week cross-over dispensing study with clariti® 1 day multifocal 3 add and 1 DAY ACUVUE® MOIST MULTIFOCAL; high add, overall (mean ratings 84 and 78 respectively, p=0.037); intermediate (mean 88 vs 81, p=0.015) and near (mean 85 vs 83, p=0.01); n=30 habitual high add MFCL wearers.
15. CVI data on file, 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 Add; with ratings from 85 to 89 out of 100; n=90 habitual multifocal contact lens wearers.
16. CooperVision data on file, 2019. clariti® 1 day Wearer Experience Survey conducted online in U.S., n=298: sphere, toric or multifocal; habitual FRP, DD, and new wearers who purchased clariti® 1 day; strongly or somewhat agree.
17. CVI data on file 2022. Verve Online Brand Survey with ECPs who recommend somofilcon A for new wearers in US, Spain, Italy, UK and Korea. N= 249 (89% strongly agree/ agree).
18. CVI data on file 2022. Verve Online Survey with US ECPs who fit clariti® 1 day or private label version. n=121 (79% strongly agree/agree).
